Answers are grounded in this paper and cite their sources.
Major advances toward a bio-based industry enabled cost-efficient bioproduction of multiple chemicals, yet successful industrial processes are relatively scarce and limited to the use of few workhorse microbes as hosts. An in-depth understanding of the physiology and metabolism of nontraditional microorganisms is key to unleash their biotechnological potential. The inception of biofoundries multiplied the capacity of constructing and testing a large number of microbial strains tailored for bioproduction - and we argue that automation workflows therein can be adapted to gain fundamental knowledge of nontraditional hosts. Here, we propose a 'metabolism-centric' approach to the design-build-test-learn cycle of synthetic biology, supported by multi-omic analyses, to facilitate the deployment of microbial cell factories designed for bioproduction beyond the typical landscape of target products.
No takes yet. Share an insight, caveat, or question.
Gurdo et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: